523.26 USD
▼-16.80-3.11%
盘后 514.56 0.00%
2026-09-15
市值
$12.09B
市盈率
—
EPS
-14.22
股息率
—
52 周区间
393.61 – 615.00
成交量
259.41K
Beta
-0.99
目标价
678.06
52W 低 393.6152W 高 615.00
价格走势
公司简介
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.